IMCR
Immunocore Holdings plc
Nasdaq Biological Products, (No Diagnostic Substances) Large accelerated filer

Key Financials

Operating Income
$-45353000
↑ 35.6%
Revenue
$400.0M
↑ 29.0%
Net Income
$-35514000
↑ 30.5%
Total Assets
$1.1B
↑ 5.7%
Shareholders' Equity
$381.0M
↑ 5.6%
EPS (Diluted)
$-0.71
↑ 30.4%
Total Liabilities
$686.2M
↑ 5.8%
Long-term Debt
$438.7M
N/A

Recent SEC Filings

Form Type Filed Date Link
4 5/28/2026 View on SEC
4 5/28/2026 View on SEC
4 5/28/2026 View on SEC
4 5/28/2026 View on SEC
4 5/28/2026 View on SEC
4 5/28/2026 View on SEC
8-K 5/27/2026 View on SEC
144 5/22/2026 View on SEC
144 5/21/2026 View on SEC
SCHEDULE 13G 5/15/2026 View on SEC

Company Information

Field Value
Ticker IMCR
Company Name Immunocore Holdings plc
CIK 1671927
Sector Biological Products, (No Diagnostic Substances)
Industry Large accelerated filer
Exchange Nasdaq
SIC Code 2836
SIC Description Biological Products, (No Diagnostic Substances)
Entity Type operating
Fiscal Year End 1231
State of Incorporation X0
Phone 01235 5430281